Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Bicara Therapeutics Inc. (BCAX) had Normalized Pre-Tax Income of $-36.77M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-36.85M |
|
-- |
|
-- |
|
$41.79M |
|
$-41.79M |
|
$5.01M |
|
$-36.77M |
|
|
Normalized Pre-Tax Income |
$-36.77M |
$-36.85M |
|
$-36.85M |
|
$-36.85M |
|
$-36.85M |
|
$-41.79M |
|
$-41.77M |
|
54.46M |
|
54.46M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$470.75M |
|
$0.14M |
|
$7.32M |
|
$478.08M |
|
$19.12M |
|
-- |
|
-- |
|
$19.12M |
|
$458.96M |
|
$458.96M |
|
$458.96M |
|
54.53M |
|
| Cash Flow Statement Financials | |
$-28.11M |
|
-- |
|
$0.46M |
|
$489.71M |
|
$462.06M |
|
$-27.65M |
|
$3.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.03% |
|
-8.03% |
|
-7.71% |
|
-8.03% |
|
$8.42 |
|
$-0.52 |
|
$-0.52 |
|